Published December 9, 2013 | Version v1
Journal article

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study

  • 1. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg (Germany)
  • 2. German Institute of Human Nutrition Potsdam-Rehbruecke Department of Epidemiology Arthur-Scheunert-Allee 114-116, 14558 Nuthetal (Germany)
  • 3. Hellenic Health Foundation, 10-12 Tetrapoleos Street, GR-115 27 Athens (Greece)
  • 4. WHO Collaborating Center for Food and Nutrition Policies, Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, 75 M. Asias Street, Goudi, GR-115 27 Athens (Greece)
  • 5. Bureau of Epidemiologic Research, Academy of Athens, 28 Panepistimiou Street, Athens GR-106 79 (Greece)
  • 6. Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115 (United States)
  • 7. Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute - ISPO, Florence (Italy)
  • 8. Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian, 1, Milan (Italy)
  • 9. Department of Clinical and Experimental Medicine, Federico II University, Naples (Italy)
  • 10. Cancer Registry and Histopathology Unit, "Civile M. P. Arezzo" Hospital, ASP 7 Ragusa (Italy)
  • 11. HuGeF Foundation, Torino (Italy)
  • 12. Center for Cancer Prevention (CPO-Piemonte), Torino (Italy)
  • 13. Public Health and Health Planning Directorate, Asturias (Spain)
  • 14. Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Granada (Spain)
  • 15. Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública-CIBERESP), Granada (Spain)
  • 16. Andalusian School of Public Health, Granada (Spain)
  • 17. Department of Epidemiology, Murcia Regional Health Authority, Murcia (Spain)
  • 18. Navarre Public Health Institute, Pamplona (Spain)
  • 19. Public Health division of Gipuzkoa, Institute BIODonostai, Health Department, Gipuzkoa, Basque Region (France)
  • 20. Department of Gastroenterology and Hepatology, University Medical Center, Utrecht (Netherlands)
  • 21. National Institute for Public Health and the Environment (RIVM), Bilthoven (Netherlands)
  • 22. Julius Center for Health Sciences and Primary Care, University Medical Center, 3508, GA, Utrecht (Netherlands)
  • 23. Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College, London (United Kingdom)
  • 24. MRC epidemiology Unit, Cambridge (United Kingdom)
  • 25. University of Cambridge, Cambridge (United Kingdom)
  • 26. Cancer Epidemiology Unit, University of Oxford, Oxford (GB)
  • 27. Samfundet Folkhälsan, Helsinki (Finland)
  • 28. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm (Sweden)
  • 29. Department of Research, Cancer Registry of Norway, Oslo (Norway)
  • 30. Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, Tromsø (Norway)
  • 31. McGill university, Montreal (Canada)
  • 32. Department of Surgery and Perioperative Sciences, Umea University, Umea (Sweden)
  • 33. Department of Oncology and Radiation Sciences, Oncology, Umeå University Hospital, Umeå (Sweden)
  • 34. Nutritional Epidemiology Group, Section of Nutrition and Metabolism, IARC, Lyon (France)
  • 35. Institute of Cancer Epidemiology, Danish Cancer Society, 2100 Copenhagen (Denmark)
  • 36. Biomarkers Group, Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), Lyon (France)
  • 37. Imperial College School of Public Health, London (GB)
  • 38. Section of Epidemiology, Department of Public Health, Aarhus University, Aarhus (Denmark)
  • 39. Paris South University, UMRS 1018, F-94805 Villejuif (France)
  • 40. Inserm, Center for Research in Epidemiology and Population Health, U1018, Institut Gustave Roussy, F-94805 Villejuif (France)

Description

The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain. Within the EPIC cohort, Cox proportional hazards models were used to describe the relationships of reproductive factors (menarcheal age, time between menarche and first pregnancy, parity, number of children, age at first and last pregnancies, time since last full-term childbirth, breastfeeding, age at menopause, ever having an abortion and use of oral contraceptives [OC]) with risk of ER-PR- (n = 998) and ER+PR+ (n = 3,567) breast tumors. A later first full-term childbirth was associated with increased risk of ER+PR+ tumors but not with risk of ER-PR- tumors (≥35 vs. ≤19 years HR: 1.47 [95% CI 1.15-1.88] ptrend < 0.001 for ER+PR+ tumors; ≥35 vs. ≤19 years HR: 0.93 [95% CI 0.53-1.65] ptrend = 0.96 for ER-PR- tumors; Phet = 0.03). The risk associations of menarcheal age, and time period between menarche and first full-term childbirth with ER-PR-tumors were in the similar direction with risk of ER+PR+ tumors (phet = 0.50), although weaker in magnitude and statistically only borderline significant. Other parity related factors such as ever a full-term birth, number of births, age- and time since last birth were associated only with ER+PR+ malignancies, however no statistical heterogeneity between breast cancer subtypes was observed. Breastfeeding and OC use were generally not associated with breast cancer subtype risk. Our study provides possible evidence that age at menarche, and time between menarche and first full-term childbirth may be associated with the etiology of both HR-negative and HR-positive malignancies, although the associations with HR-negative breast cancer were only borderline significant

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-13-584; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866571

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
13
Journal Page Range
p. 584
ISSN
1471-2407

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46123865
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
HAZARDS; HORMONES; MAMMARY GLANDS; MENOPAUSE; NEOPLASMS; PARITY; PARTURITION; PREGNANCY
Descriptors DEC
BODY; DISEASES; GLANDS; ORGANS; PARTICLE PROPERTIES

Optional Information

Copyright
Copyright (c) 2013 Ritte et al.
Notes
PMCID: PMC3866571; PUBLISHER-ID: 1471-2407-13-584; PMID: 24321460; OAI: oai:pubmedcentral.nih.gov:3866571; licensee BioMed Central Ltd.